Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor
- 1 April 1997
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 7 (1) , S23-S35
- https://doi.org/10.1016/s0924-977x(97)00417-3
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995
- Genetically variable metabolism of antidepressants and neuroleptic drugs in manPharmacogenetics, 1993
- Comparison of the disposition and of the metabolic pattern of Reboxetine, a new antidepressant, in the rat, dog, monkey and manEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Preparation of 2‐[α‐(2‐ethoxyphenoxy)benzyl]‐[5‐14C]morpholine methanesulfonate ([14C]reboxetine) a new antidepressant agentJournal of Labelled Compounds and Radiopharmaceuticals, 1991
- Alteration of cytochrome P-450 by prolonged administration of imipramine and/or lithium to ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- FluoxetineDrugs, 1986
- The effect of antidepressants on ethylmorphine and imipramine N-demethylation in rat liver microsomesJournal of Pharmacy and Pharmacology, 1986
- Age Effects on Alpha‐1‐Acid Glycoprotein Concentration and Imipramine Plasma Protein BindingJournal of the American Geriatrics Society, 1984
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982